Journal of Clinical Endocrinology & Metabolism, Vol 59, 734-738, Copyright © 1984 by Endocrine Society

ARTICLES

Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease

U Bogner, H Schleusener and JR Wall

Antibody-dependent cell-mediated cytotoxicity (ADCC) against human thyroid cell targets was measured in a chromium release assay, using serum from patients with autoimmune thyroid diseases. The source of effector cells was peripheral blood mononuclear cells from normal subjects. Mean (+/- SD) specific lysis produced by serum from patients with Hashimoto's thyroiditis was 27.3 +/- 6.1%, compared to 10.6 +/- 4.7% produced by serum from normal subjects and 13.3 +/- 10% using serum from patients with Graves' hyperthyroidism. Cytotoxicity using serum from hyperthyroid patients was not different after treatment. Thyroid cell targets from histologically different thyroid cell preparations (Graves' disease, multinodular goiter, normal thyroid) were equally sensitive to killing, although cells from a benign thyroid adenoma were much less sensitive. A strong positive correlation was found between percent specific lysis and titers of serum microsomal antibody. By addition of patients' immunoglobulin to normal serum, we found that microsomal antibodies were responsible for the cytotoxic effect, whereas thyroglobulin antibodies did not mediate cytotoxicity. These results demonstrate that ADCC plays an important role in the thyroid cell destruction of chronic (Hashimoto's) thyroiditis. Although cytotoxic activity was associated with the antimicrosomal-, but not antithyroglobulin-, positive immunoglobulin G fraction, it is not clear whether the microsomal antibody itself, or an unidentified antibody occurring in the same antibody fraction, is the mediator of cytotoxicity in this disorder.

This article has been cited by other articles:

				S. A. Rebuffat, B. Nguyen, B. Robert, F. Castex, and S. Peraldi-Roux Antithyroperoxidase Antibody-Dependent Cytotoxicity in Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 929 - 934. [Abstract] [Full Text] [PDF]

				H. P. Ng and A. W. C. Kung Induction of Autoimmune Thyroiditis and Hypothyroidism by Immunization of Immunoactive T Cell Epitope of Thyroid Peroxidase Endocrinology, June 1, 2006; 147(6): 3085 - 3092. [Abstract] [Full Text] [PDF]

				J. Guo, S. M. McLachlan, P. N. Pichurin, C.-R. Chen, N. Pham, H. A. Aliesky, C. S. David, and B. Rapoport Relationship between Thyroid Peroxidase T Cell Epitope Restriction and Antibody Recognition of the Autoantibody Immunodominant Region in Human Leukocyte Antigen DR3 Transgenic Mice Endocrinology, November 1, 2005; 146(11): 4961 - 4967. [Abstract] [Full Text] [PDF]

				V. Estienne, C. Blanchet, P. Niccoli-Sire, C. Duthoit, J.-M. Durand-Gorde, C. Geourjon, D. Baty, P. Carayon, and J. Ruf Molecular Model, Calcium Sensitivity, and Disease Specificity of a Conformational Thyroperoxidase B-cell Epitope J. Biol. Chem., December 10, 1999; 274(50): 35313 - 35317. [Abstract] [Full Text] [PDF]

				M. Okumura, Y. Hidaka, S. Kuroda, K. Takeoka, H. Tada, and N. Amino Increased Serum Concentration of Soluble CD30 in Patients with Graves' Disease and Hashimoto's Thyroiditis J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1757 - 1760. [Abstract] [Full Text] [PDF]

				J. Guo, J. C. Jaume, B. Rapoport, and S. M. McLachlan Recombinant Thyroid Peroxidase-Specific Fab Converted to Immunoglobulin G (IgG) Molecules: Evidence for Thyroid Cell Damage by IgG1, but Not IgG4, Autoantibodies J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 925 - 931. [Abstract] [Full Text] [PDF]